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Introduction
Gastric cancer is the fourth most common cancer and
the second cause of cancer-related death worldwide 
1–3.
Various types of gastric cancers differ in their epidemiology,
pathogenesis, genetic profile and clinical outcome 
4. There
has been the overall decline in the total incidence of gastric
cancer in the last few decades worldwide, but the decline of
signet ring cell (SRC) type of gastric carcinoma has been
more gradual and some studies have even reported an in-
crease of SRC type carcinoma 
5. As a result, there are differ-
ent data about incidence of SRC carcinoma - it has been re-
ported that 3.4 – 29% of patients with gastric cancer had
SRC type histology and the newest data say that SRC carci-
noma accounts for more than 30% of gastric carcinomas in
some reported series 
4–7.
Comparing with other types of gastric cancer, SRC
gastric carcinoma has a tendency to involve the entire
stomach and to extend directly into neighboring organs. It
has the poorest prognosis, is more common in females than
males and occurs at a comparatively younger age 
8. Al-
though most researchers believe that SRC carcinoma is
characterized by poor differentiation, strong invasive ten-
dency and poor prognosis, the clinicopathologic parameters
of this type of malignancy are still controversial 
8–10. Con-
troversial reported data on gastric SRC cancer incidence,
prognosis, histogenesis, metastasis, phenotipic histologic
and immunohistochemical features, and confusion induced
by the presence of morphologic patterns other than the
conventional appearance, are the facts that require further
investigations 
8–15.
Classifications of gastric carcinoma
Histologic classifications
Gastric carcinomas have been classified into two main
histologic subtypes by standard hematoxylin-eosin staining
according to their gland-forming tendencies, intestinal and
diffuse type according to Lauren 
16, which essentially corre-
spond to the differentiated and undifferentiated types, re-
spectively, according Nakamura et al. 
17.
Intestinal carcinoma was considered to be almost
equal to differentiated carcinoma, and diffuse carcinoma
was considered almost equal to gastric or undifferentiated
carcinoma 
18.
Neoplasms that contain approximately equal quantities
of intestinal and diffuse components are called mixed carci-
nomas. Carcinomas too undifferentiated to fit neatly into ei-
ther category are placed in the indeterminate category 
16.
Intestinal carcinomas form recognizable glands that
range from well differentiated tumors, sometimes with
poorly differentiated tumor at the advancing margin. They
typically arise on the background of intestinal metaplasia 
19.
Diffuse carcinomas consist of poorly cohesive cells dif-
fusely infiltrating the gastric wall with little or no gland for-
mation. The cells usually appear round and small, either ar-
ranged as single cells or clustered in abortive, lacy gland-like
or reticular formations. These tumors resemble those classi-
fied as SRC tumors in the Wored Health Organisation
(WHO) classification. The mitotic rate is lower in diffuse
carcinomas than in intestinal tumors. Desmoplasia is more
pronounced and associated inflammation is less evident in
diffuse cancers than in the intestinal carcinomas 
19.Strana 836 VOJNOSANITETSKI PREGLED Volumen 65, Broj 11
Krstić M, Katić V. Vojnosanit Pregl 2008; 65(11): 835–838.
With respect to histogenesis of these two types of gas-
tric carcinoma, intestinal/differentiated type tumors have
generally been considered to arise from the gastric mucosa
with intestinal metaplasia and diffuse/undifferentiated type
tumors from the ordinary gastric mucosa without intestinal
metaplasia, and the two are considered to follow different
genetic pathways during carcinogenesis 
16–21.
  However, recent reports have shown that gastric
and intestinal phenotypic cell markers are widely expressed
in gastric carcinomas, irrespective of their histological
type 
22–25.
World Health Organization classification
This classification is based on the predominant his-
tological pattern. More than 50% of SRC carcinomas consist
of isolated or small groups of malignant cells containing in-
tracytoplasmic mucin. Superficially, SRC lie scattered in the
lamina propria, widening the distances between the pits and
glands. The tumor cells have five morphologies: nuclei push
against cell membranes creating a classical signet ring cell
appearance due to an expanded, globoid, optically clear cy-
toplasm 
26. These contain acid mucin and stain with Alcian
blue at pH 2.5 (Figure 1); other diffuse carcinomas contain
cells with central nuclei resembling histiocytes, and show
little or no mitotic activity;  small deeply eosinophilic cells
with prominent, but minute cytoplasmic granules containing
neutral mucin; small cells with little or no mucin, and ana-
plastic cells with little or no mucins (Figure 2). These cell
types intermingle with one another and constitute varying
tumor proportions. SRC tumors may also form lacy or deli-
cate trabecular glandullar patterns and they may display a
zonal or solid arrangement.
Signet ring cell carcinomas are infiltrative; the number
of malignant cells is comparativelly small and desmoplasia
may be prominent. Histochemical stains, including mucin
stains (PAS, Alcian blue, HID-AB at pH 2.5) or immuno-
histochemical staining with antibodies to cytokeratin, help
detect sparsely dispersed tumor cells in the stroma. Cyto-
keratin immunostains detect a greater percentage of neoplas-
tic cells than do mucin stains (Figure 3).
Fig. 2 – Signet ring cell gastric carcinoma – Hypersecretion
of gastric neutral mucin (AB-PAS, pH=2, 5; × 200)
Fig. 3 – Signet ring cell gastric carcinoma – Strong diffuse
expression of pancytokeratin (LSAB2; × 200)
Several conditions mimic SRC carcinoma including
signet ring lymphoma, gastric mucosa associated lymphoid
tissue (MALT) lymphoma, gastrointestinal stromal tumor
(GIST), lamina propria muciphages, xantomas and detached
or dying cells associated with gastritis 
15, 26.
Phenotypic classification
Mucin histochemical and immunohistochemical meth-
ods enabled phenotypic classification of gastric cancers
based on mucin expression profile.
Mucins are high molecular weight heavily O-
glucosylated glycoproteins produced by secretory epithelial
cells, that have many physiologic roles in normal tissues
12, 27, 28. Specific types of mucin are individually referred to as
MUC and designated with a number representing the order in
which the mucin was described. Secretory mucins (MUC2,
MUC5AC, MUC5B, and MUC6) act as a first-line defense
as physical protective barriers for epithelial surfaces. An-
other subset of mucins, transmembrane type (MUC1,
MUC3A, MUC3B, MUC4, MUC12, and MUC17), may
serve as ligands and modulators in cell signaling 
28. Mucins
have many physiologic functions as well as distinct patho-
logic changes in tumor and metastasis. Several protective
functions as well as additional pathologic mechanisms of
mucins have been proposed in cancer including protection
Fig. 1 – Signet ring cell gastric carcinoma – Hypersecretion
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from host response, decreased cell adhesion, tumor invasion,
and other changes in metastatic potential 
28. These two fami-
lies of mucins, secretory and transmembrane, represent most
of the clinically relevant mucins that have been described 
27.
In gastric mucosa, two types of mucus-secreting cells
exist: the surface mucous cells and gland mucous cells
(which includes cardiac gland cells, mucous neck cells, and
pyloric gland cells) 
12.
The mucin expression pattern of gastric carcinoma is
heterogeneous. It includes mucins normally expressed in
gastric mucosa – gastric phenotypic markers (MUC1,
MUC5AC and MUC6) and de novo expression of the intesti-
nal mucin – intestinal phenotypic marker MUC2 
11, 27.
According to the expression of phenotypic markers,
SRC carcinomas  are classified into four differentiated
phenotypes 
22. G type (tumors that are positively stained by
one or more gastric phenotypic markers, but no intestinal
phenotypic marker); I type (those stained by one or more
intestinal phenotypic markers, but no gastric marker);  GI
(mixed) type (those positively stained by both gastric and
intestinal phenotypic markers) and  UC (unclassified type)
(those stained by none of the phenotypic markers) (Figures
4–6).
Fig. 4 – Signet ring cell gastric carcinoma – Intensive
expression of MUC6 (LSAB2; × 400)
Fig. 5 – Signet ring cell gastric carcinoma – Multifocal weak
expression of MUC2 (LSAB2; × 400)
Fig. 6 – Signet ring cell gastric carcinoma – Diffuse intensive
expression of MUC5AC (LSAB2; × 400)
Signet ring cell carcinoma can be easily missed on initial
microscopic examination due to inconspicuousness of the tu-
mor cells and marked desmoplasia. In addition, the WHO clas-
sification provides five morphologic patterns of tumor cells,
other than the conventional appearance, inducing a great diag-
nostic difficulty. This different morphology, and possible
similarity with epitheloid GIST, hepatoid variant of gastric
carcinomas, MALT lymphomas, xantomas, and marked in-
flammatory and desmoplastic reaction (coupled with the in-
conspicuousness of the tumor cells) enter the list of diagnostic
possibilities. However, the histochemistry for mucin and im-
munohistochemical positivity for panCytokeratin and negativ-
ity for CD117, SMA, S-100 protein, CD20 and CD45Rö, ex-
clude this diagnostic possibility. In addition to, specific anti-
bodies to the various kinds of mucins (MUC1, MUC2, MUC6,
MUC5AC, MUC10) are also used to define gastric and intes-
tinal phenotypes, to provide new insights in the differentiation
pathways of the gastric carcinomas.
A number of clinical studies revealed the difference in
biological behaviors and prognosis among patients with gas-
tric SRC carcinoma, indicating that morphologic classifica-
tion is not enough to predict the progression and outcome of
this kind of gastric carcinoma, and subtype classification
needs further investigations 
9, 22, 25. Our previous study
showed that different phenotipic expression patterns were
significantly associated with clinicopathologic parameters
and prognosis of SRC carcinoma of the stomach 
29–32.
Conclusion
Numerous morphologic variations of SRC carcinoma
pose an important diagnostic dilemma.
Various epithelial, stromal and lymphomatous tumors,
and xantomatous gastritis enter the list of diagnostic possi-
bilities. The accurate diagnosis is essential for therapeutic
and prognostic considerations.
Immunohistochemistry is “gold standard” for SRC car-
cinoma diagnosis.
Examination of phenotype expression may be useful
evidence for further classification and prognostic prediction
in gastric SRC carcinomas.Strana 838 VOJNOSANITETSKI PREGLED Volumen 65, Broj 11
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